Open company graph database — free web & API
Login

Shionogi Smile Heart Co., Ltd.

シオノギスマイルハート株式会社SHIONOGI SMILE HEART CO., LTD.Alias
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
55
Related companies
16
§01

Basic information

BASIC
Head office
3-2-1 Futabacho, Toyonaka, Osaka 561-0825, Japan
Chief executive
Hiroyuki Tanaka
Capital
20,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
55 people
Start date
2018-04-01
End date
§02

Websites

1 DOMAINS
§03

Business

0
§04

Related companies

16 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Gloridge
Suntory
Shionogi & Co., Ltd.
Shionogi Healthcare Co., Ltd.
Shionogi Inc.
V:DRIVE
Verizon社
Asahi Group Japan subsidiary, Asahi Beverage Co., Ltd.
シオノギキャリア開発センター株式会社
Shionogi Business Partner Co., Ltd.
Shionogi Pharma Co., Ltd.
Shionogi Healthcare Co., Ltd.
全国食支援活動協力会
Osaka Industrial Bureau Foundation
UMN Pharma Co., Ltd.
Oil Japan Agro Research Co., Ltd.
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

23 EVENTS

Saburo Shiono, who learned the drugstore business from his father, Yoshie, founded the drugstore 'Shiono Saburo Store' at 3-12 Doshomachi, Osaka, on his 24th birthday, March 17, 1878.Sources

Initially dealing mainly with Kampo medicines, in 1886, eight years after founding, Western medicine began to be imported and sold as Western medicine became widespread.Sources

With the graduation of Saburo's second son, Chojuro, from the Department of Pharmacology at Tokyo Imperial University, SHIONOGI began full-scale pharmaceutical research. During this time, the managing pharmacist of Shiono Saburo Store learned from a pediatrician at Osaka Medical College (now Osaka University School of Medicine) that antacid formulations were written in German medical books. Chojuro started trial manufacturing of these antacids and succeeded in productization. This stomach medicine and antacid 'Antacidin' became the first self-developed new drug by Shiono Saburo Store.Sources

Trust and credibility are said to be essential for management. Since its founding, trust and credibility have been the greatest 'capital' for Shiono Saburo Store. The SHIONOGI symbol is derived from the 'Funda' used to weigh medicines on a balance. The Funda symbolizes 'accuracy,' 'honesty,' and 'trust,' reflecting SHIONOGI's constant pursuit of precision.Sources

After successfully developing 'Antacidin,' Saburo built a pharmaceutical factory called 'Shiono Pharmaceutical Plant' in Nishinari District, Osaka (now Fukushima Ward, Osaka City) to expand into full-scale drug manufacturing. This marked the moment SHIONOGI officially became a pharmaceutical company.Sources

In 1919, a year after the end of World War II, to further develop SHIONOGI, Saburo's eldest son, Shotaro, merged the drugstore and pharmaceutical business, Shiono Saburo Store, managed by him, with the pharmaceutical company, Shiono Pharmaceutical Plant, run by his second son, Chojuro, forming Shiono-Yoshi Commercial Co., Ltd.Sources

In 1943, the company name was changed to Shiono-Yoshi Pharmaceutical Co., Ltd.Sources

Following the end of the war, rapid inflation and soaring prices caused chaos, leading to frozen corporate deposits and the termination of wartime compensation, which nearly bankrupted SHIONOGI and put it in its worst management condition since founding.Sources

In 1948, the company announced the 'Three Major Goals to Overcome the Crisis' (1. Raising all technologies, 2. Thorough goal setting and confirmation, 3. Beautification) and started efforts to improve management.Sources

Launched the painkiller 'Sedes'.Sources

To unify the pharmaceutical business, the company transferred and delegated the sale of herbal medicines, animal medicines, and pharmaceutical wholesale to other companies. To speed up research and development, a subsidiary was established in the U.S. in 2001, and joint development of new drugs with GlaxoSmithKline in the UK began.Sources

From April 2005 to March 2010.Sources

From April 2010 to March 2014.Sources

In 2011, the company acquired C&O Pharmaceutical Technology (Holdings) Limited, a Chinese pharmaceutical company.Sources

In 2012, the company established Shionogi Limited, a development subsidiary, in the UK.Sources

From April 2014 (Heisei 26), the New Medium-Term Management Plan sets a vision to 'grow as a drug discovery-oriented pharmaceutical company,' establishing ROE (Return on Equity) as one of the management indicators, clarifying the items to be achieved over the past three years, and confirming results and issues annually in a rolling manner, clearly demonstrating efforts toward the management goal for 2020.Sources

From May 2016 (Heisei 26).Sources

From June 2020 (Reiwa 2).Sources

Joint venture with Shimadzu Corporation, establishment of AdvanSentinel CorporationSources

Establishment of the general incorporated foundation, Shionogi Infectious Disease Research Promotion FoundationSources

Development of the SHIONOGI group brand and establishment of the group brand markSources

Establishment of Yui Connection Co., Ltd.Sources

Launch of the COVID-19 treatment drug 'Zocova'Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information1120901039735
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
シオノギスマイルハート株式会社
Trade name (kana)
シオノギスマイルハート
Name in English
Corporation type
301
Address
〒561-0825 大阪府豊中市二葉町3丁目2番1号
Postal code
5610825
Prefecture code
27
City code
203
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2018-04-10
Update date
2018-04-13
Change date
2018-04-10
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
0
Trade name image ID
Address image ID
Sequence number
4026665
METI gBizINFO1120901039735
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
1120901039735
Trade name
シオノギスマイルハート株式会社
Trade name (kana)
シオノギスマイルハート
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府豊中市二葉町3丁目2番1号
Postal code
5610825
Prefecture
大阪府
Prefecture code
27
City or district
豊中市
City code
203
Street address
二葉町3丁目2番1号
Organisation type
301
Processing type
01
Correction type
0
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-04-13
Key information
1120901039735
§09

Sources & updates

SOURCES
↑